Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...
Researchers at the Manchester Institute of Biotechnology (MIB) have used engineering biology—an emerging technology that uses ...
Gilead HQ, 10:30 a.m. -11:30 a.m. HIV drug maker’s pricing for its lifesaving HIV drugs puts nation’s HIV safety nets under tremendous strain; one Gilead’s HIV medication, Biktarvy, carried an annual ...
Lenacapavir, which Gilead markets in the U.S. as Yeztugo, has become widely sought because it requires only two injections ...
A long-standing belief about HIV has quietly shaped how scientists think about the virus. For decades, researchers described ...
A man with HIV has gone into remission after receiving bone marrow from his brother, who has a rare mutation that prevents ...
Charles and Patrick Boyd were sentenced to long prison terms by a Fort Lauderdale federal judge for distributing black-market HIV drugs to unwitting customers nationwide. Miami Herald File Two ...
Global health is evolving rapidly, with breakthroughs turning into medicine. The latest advancement in viral research is ...
By Ben Ezeamalu and Jennifer Rigby MAKURDI, Nigeria, March 31 (Reuters) - For several months last year, Josephine Angev ...
U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in ...
Ciara licensed the rights to her song to Gilead, returning to the studio to re-record the lyrics for their "One2PrEP" ...
Learn why the new HIV injection, Lenacapavir, faces a slow rollout in Abuja. Officials cite logistical hurdles and limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results